FibroBiologics Cell Therapy Preserves Disc Height in 12-Week Rabbit Study

• FibroBiologics reported preclinical results showing fibroblast spheroid-derived chondrocyte spheroids preserved disc height better than other tested fibroblast treatments in rabbits.
• The degenerative disc disease study evaluated single injections of three cell preparations over 12 weeks.
• At 12 weeks, normalized disc height index reached 80.7% with chondrocyte spheroids versus 71.8% in controls (p<0.05).
• All three treatments significantly improved disc height versus controls; chondrocyte spheroids maintained significantly higher values than other treatments throughout the study.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fibrobiologics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610190830PR_NEWS_USPR_____DA74930) on October 19, 2026, and is solely responsible for the information contained therein.